Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (281)	7/13/1998 7:59:00 PM
From: Caveat Emptor	Respond to of 410

Recent Insider Shift Information. Recent 13D filing of Paine Webber R+D Partners 11. Transfer of ownership of partnership interest to BIOROYALTIES LLC Research has found that Paine Webber R+D Partners 11 has been a significant stockholder and Investment Service of Genzyme since 1989. to review 13D sec.gov click into Edgar type - BIOROYALTIES at prompt Research this transaction, as well as previously filed 10K of Paine Webber R+D 11 for background of Genzyme Ownership. Any comments on this? More information to follow. CAVEAT EMPTOR

To: Vector1 who wrote (281)	7/13/1998 8:16:00 PM
From: Caveat Emptor	Read Replies (1) \| Respond to of 410

Further Information-Insider Shift and General Partnership It is important that we understand the breakdown of this partnership/Venture Funding unit of Genzyme. This recent shift of partnership units may have profited the General Partners. The General Partners are Executives of the Company. Genzyme Development PArtners, LP Organized October 16, 1989 - MA Agent: Peter Wirth, Esq. - As Secretary of GP Directors and Officers of GDP, LP * Henri Termeer - President and Director since 1989 * Peter N. Reikes - Director since 1996 Reikes is Managing Director of the Health Care Group within the Investment Banking Division of Paine Webber (since 1985) (Appointed to board by PW R+D Partners 11) * W. Gerald Austien, MD - Appointed to Board - 1990 Appointed by PW R+D Partners 11 David J. McLachlan - Director since 1990 Earl M. Collier, Jr - Director since 1997 Comments or questions? I would welcome a discussion on this issue. Thanx CAVEAT EMPTOR

To: Vector1 who wrote (281)	7/16/1998 10:30:00 AM
From: Caveat Emptor	Read Replies (3) \| Respond to of 410

Who is Geoff Cox + Greg Phelps?-Insiders took major profit Information taken from the Insider Trading Report - Yahoo FInance 7/14/98 GEOFFREY COX - Between 9/3/97 - 1/2/98 Sold close to 145,000 Shares of Genzyme Common Stock (no including options) - Total Value- CLose to $4.2 Million!! GREGORY PHELPS - Between 7/29-7/30/97 Sold close to 175,000 shares of common stock (not including options) Total Value - close to 4.6 Million!!!! Who are these two guys? I cannot find them on filings as recent officers/directors of Genzyme. Are they retired? Are they with one of the Subsidiaries? Whoever they are... they just did quite nicely.. Any comments? CAVEAT EMPTOR